Nordmark Pharma GmbH

General information
Nordmark Pharma GmbH
Pinnauallee 4
25436 Uetersen, Schleswig-Holstein
Germany

Contact person: Jörn Ton, Managing Director
Company main phone: +49 (4122) 7120
Company main fax:  +49 (4122) 712220
Website:  www.nordmark-pharma.de
Year founded:2001
Source of foundation:Management buy-out (MBO)
Name of foundation source:BASF Group
No. of employees: Worldwide:  550
Corporate description / mission:
Nordmark are specialists in the manufacture of active pharmaceutical ingredients and drug products of biological origin. The pharmaceutical products in Nordmark’s product portfolio contain active ingredients produced in-house, such as pancreatin, heparin and Pepsin Ph. Eur.

The company's work is aimed at continuously optimising existing production processes and developing innovative biological active pharmaceutical ingredients and drug products. In doing so, they service the full process range, from extraction, fermentation, purification and characterisation of proteins, via the development of the required analytical procedures, all the way to establishing GMP compliant manufacturing processes and the performance of ICH compliant stability studies, method validations and formulation of the finished pharmaceutical product.
State of ownership: Private / independent
Headquarters: Yes
Categorization
Sector:
  • Biotechnology - R&D Services
Subsector:
  • Analytical services
  • Cell culture
  • CMO (Contract Manufacturing Organization)
  • Proteomics
Business model:
  • Manufacturer
  • R&D
  • Service company
  • Supplier / Distributor
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Distribution:
  • Direct (own sales force)
Summary Products / Services / Technologies
Description of products:
Products:

Collagenase NB
Pancreatin powder
Pancreatin pellets, etc.

Services:

Development/optimisation of strains or cell cultures
Fermentation
Protein purification
Scale-up
Development of the formulation
Manufacture of clinical samples
Support in clinical trials and regulatory discussions.
X